Nebulised colistin for ventilator-associated pneumonia prevention

European Respiratory Journal

Volumn 46, Issue 6, 2015, Pages 1732-1739

  Karvouniaris, Marios ^a   Makris, Demosthenes ^a   Zygoulis, Paris ^a   Triantaris, Apostolos ^a   Xitsas, Stelios ^a   Mantzarlis, Konstantinos ^a   Petinaki, Efthimia ^a   Zakynthinos, Epaminondas ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COLISTIN;

ADULT; AGED; CONTROLLED STUDY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTIDRUG RESISTANCE; NEBULIZER; PNEUMONIA, VENTILATOR-ASSOCIATED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADULT; AGED; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME;

EID: 84948990441     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02235-2014     Document Type: Article

References (31)

1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903.
2. Rello J, Ollendorf DA, Oster G, et al. VAP Outcomes Scientific Advisory Group: epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122: 2115-2121.
3. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001; 29: 2303-2309.
4. ATS. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
5. Bouderka MA, Fakhir B, Bouaggad A, et al. Early tracheostomy versus prolonged endotracheal intubation in severe head injury. J Trauma 2004; 57: 251-254.
6. Karvouniaris M, Makris D, Manoulakas E, et al. Ventilator-associated tracheobronchitis increases the length of intensive care unit stay. Infect Control Hosp Epidemiol 2013; 34: 800-808.
7. Nseir S, Blazejewski C, Lubret R, et al. Risk of acquiring multidrug resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 2011; 17: 1201-1208.
8. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36: 2008-2013.
9. Rouby JJ, Poete P, Martin de Lassale E, et al. Prevention of Gram-negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study. Intensive Care Med 1994; 20: 187-192.
10. Klick JM, du Moulin GC, Hedley-Whyte J, et al. Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients. J Clin Invest 1975; 55: 514-519.
11. Feeley TW, Du Moulin GC, Hedley-Whyte J, et al. Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975; 293: 471-475.
12. Whonet Greece. Cumulative results of Jan-Jun 2012. http://www.mednet.gr/whonet. Date last accessed: June 26, 2013.
13. Makris D, Manoulakas E, Komnos A, et al. Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study. Crit Care Med 2011; 39: 2440-2446.
14. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD. http://www.who.int/respiratory/copd/GOLD-WR-06.pdf. Date last accessed: September 21, 2011.
15. Ari A, Areabi H, Fink JB. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care 2010; 55: 837-844.
16. Mead R, Curnow R. Statistical methods in agriculture and experimental biology (Texts in statistical science). New York, Chapman & Hall, 1983; p. 34.
17. Craven DE, Chroneou A, Zias N, et al. Ventilator-associated tracheobronchitis (VAT): the impact of targeted antibiotic therapy on patient outcomes. Chest 2008; 135: 521-528.
18. Nseir S, Favory R, Jozefowicz E, et al. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized controlled multicenter study. Crit Care 2008; 12: R62.
19. Bouadma L, Deslandes E, Lolom I, et al. Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 2010; 51: 1115-1122.
20. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med 2007; 101: 1305-1312.
21. de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360: 20-31.
22. Michalopoulos A, Papadakis E. Inhaled anti-infective agents: emphasis on colistin. Infection 2010; 38: 81-88.
23. Athanassa ZE, Markantonis SL, Fousteri M-Z, et al. Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients. Intensive Care Med 2012; 38: 1779-1786.
24. Rattanaumpawan P, Lorsutthitham J, Ungprasert P, et al. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J Antimicrob Chemother 2010; 65: 2645-2649.
25. Lu Q, Luo R, Yang J, et al. Efficacy of high-dose nebulized colistine in ventilator-associated pneumonia caused by multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Anesthesiology 2012; 117: 135-147.
26. Rouby JJ, Bouhemad B, Monsel A, et al. Aerosolized antibiotics for ventilator-associated pneumonia. lessons from experimental studies. Anesthesiology 2012; 117: 1364-1380.
27. Kassamali Z, Rotschafer JC, Jones RN, et al. Polymyxins: wisdom doesn't always come with age. Clin Infect Dis 2013; 57: 877-883.
28. Ratjen F, Rietschel E, Kasel D, et al. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother 2006; 57: 306-311.
29. Lu Q, Girardi C, Zhang M, et al. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med 2010; 36: 1147-1155.
30. Caruso P, Denari S, Ruiz S, et al. Saline instillation before tracheal suctioning decreases the incidence of ventilator-associated pneumonia. Crit Care Med 2009; 37: 32-38.
31. Palmer LB, Smaldone GC. Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit. Am J Respir Crit Care Med 2014; 189: 1225-1233.